Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Double-Blind Study of Z-103 in Zinc-Deficient and Idiopathic Taste Disorders
jRCT2080220228Phase 3
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Apr 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Gustatory Dysfunction comparing Z-103 arm with Placebo arm (2 arms).
02
Drugs
polaprezinc
03
Conditions
Gustatory Dysfunction
Beyond the preview
Go deeper on jRCT2080220228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220228.